NuGen Medical Devices Inc (V:NGMD) — Stock Price
NuGen Medical Devices Inc (V:NGMD) is currently trading at CA$0.02 CAD, down 25.00% today. Over the past 52 weeks, shares have ranged between CA$0.02 and CA$0.06. This page tracks NuGen Medical Devices Inc's live share price on the V exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see NGMD market cap overview.
NuGen Medical Devices Inc (NGMD) Stock Price Chart — Daily History & Trading Volume
The chart below tracks NuGen Medical Devices Inc's daily closing share price and trading volume on the V exchange over the past year, giving a clear view of recent price momentum and liquidity.
NuGen Medical Devices Inc Income Statement — Revenue, Profit & Earnings by Year
NuGen Medical Devices Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CA$257.95K | CA$1.01 Million | CA$331.40K | CA$152.36K | CA$137.65K |
| Cost of Revenue | CA$125.60K | CA$487.94K | CA$166.56K | CA$53.19K | CA$45.42K |
| Gross Profit | CA$132.35K | CA$521.94K | CA$164.84K | CA$99.17K | CA$92.22K |
| Research & Development | — | — | — | — | — |
| SG&A | CA$3.66 Million | CA$5.03 Million | CA$7.52 Million | CA$4.24 Million | CA$7.76 Million |
| Total Operating Expenses | CA$4.48 Million | CA$6.17 Million | CA$8.37 Million | CA$4.94 Million | CA$7.81 Million |
| Operating Income | CA$-4.22 Million | CA$-5.16 Million | CA$-8.04 Million | CA$-4.79 Million | CA$-7.67 Million |
| EBITDA | — | — | — | — | CA$-5.09 Million |
| EBIT | — | — | — | — | CA$-5.79 Million |
| Interest Expense | CA$3.06 Million | CA$1.67 Million | CA$1.24 Million | CA$1.01 Million | CA$1.22 Million |
| Income Before Tax | CA$-7.77 Million | CA$-5.22 Million | CA$-9.33 Million | CA$-5.57 Million | CA$-7.10 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | CA$-7.83 Million | CA$-5.23 Million | CA$-9.36 Million | CA$-5.58 Million | CA$-7.11 Million |
NuGen Medical Devices Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes NuGen Medical Devices Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CA$4.29 Million | CA$12.89 Million | CA$6.95 Million | CA$6.85 Million | CA$8.84 Million |
| Total Current Assets | CA$3.99 Million | CA$7.80 Million | CA$1.33 Million | CA$566.83K | CA$2.15 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CA$50.71K | CA$99.96K | CA$20.75K | CA$5.74K | CA$11.22K |
| Inventory | CA$498.23K | CA$320.73K | CA$209.28K | CA$76.77K | CA$12.90K |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | CA$0.00 | CA$1.86 Million | CA$1.69 Million | CA$1.67 Million | CA$1.67 Million |
| Total Liabilities | CA$18.03 Million | CA$18.57 Million | CA$9.01 Million | CA$9.11 Million | CA$7.19 Million |
| Total Current Liabilities | CA$3.63 Million | CA$1.34 Million | CA$3.29 Million | CA$1.73 Million | CA$1.23 Million |
| Long-term Debt | CA$14.40 Million | CA$17.23 Million | CA$5.72 Million | CA$7.16 Million | CA$5.61 Million |
| Net Debt | CA$14.24 Million | CA$10.86 Million | CA$7.39 Million | CA$7.11 Million | CA$4.18 Million |
| Total Stockholder Equity | CA$-13.74 Million | CA$-5.67 Million | CA$-2.06 Million | CA$-2.26 Million | CA$1.66 Million |
| Retained Earnings | CA$-40.83 Million | CA$-34.37 Million | CA$-29.30 Million | CA$-20.61 Million | CA$-15.81 Million |
NuGen Medical Devices Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how NuGen Medical Devices Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CA$-3.57 Million | CA$-4.71 Million | CA$-6.71 Million | CA$-4.88 Million | CA$-4.10 Million |
| Capital Expenditures | CA$302.31K | CA$10.38K | CA$3.02K | CA$1.01K | CA$3.57K |
| Free Cash Flow | CA$-3.87 Million | CA$-4.72 Million | CA$-6.72 Million | CA$-4.89 Million | CA$-4.10 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | CA$60.50K | CA$11.21 Million | CA$7.10 Million | CA$4.85 Million | CA$5.58 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | CA$0.00 | CA$94.69K | CA$1.36 Million | CA$1.59 Million | CA$1.31 Million |
| Depreciation | CA$691.07K | CA$645.73K | CA$690.84K | CA$727.28K | CA$626.94K |
| Change in Cash | CA$-3.81 Million | CA$6.48 Million | CA$333.01K | CA$-2.29K | CA$1.47 Million |
NuGen Medical Devices Inc Earnings History — EPS Actual vs. Analyst Estimates
Track NuGen Medical Devices Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 27, 2026 | — | — | — |
| May 28, 2026 | — | — | — |
| Nov 28, 2025 | — | — | — |
| Aug 28, 2025 | — | — | — |
| May 29, 2025 | — | — | — |
| Nov 27, 2024 | — | — | — |